Inform brain health with accurate insights
Use our innovative blood tests to get a clear picture of Alzheimer's disease pathology.
The Precivity™ tests are innovative new blood tests intended for use in patients 55* and older with signs or symptoms of mild cognitive impairment or dementia. These tests aid healthcare providers in the detection of amyloid plaques in the brain, a pathological hallmark of Alzheimer's disease, and inform medical management and treatment decisions.
*Precivity-ApoE™, blood test is intended for use in patients aged 18 and older.
Learn more about C2N Diagnostics and the development of the Precivity™ blood tests for Alzheimer’s disease
Recent News
Webinars
